What will Johnson & Johnson say during their next earnings call?
$43,288 交易量
Jan 21, 2026
Nipocalimab / Lupus
$339 交易量
Yes
Nipocalimab / Lupus
$339 交易量
Yes
Halda Therapeutics / Haida Therapeutics
$4,472 交易量
是
Halda Therapeutics / Haida Therapeutics
$4,472 交易量
是
Darzalex Faspro
$266 交易量
No
Darzalex Faspro
$266 交易量
No
Ottava
$7,631 交易量
Yes
Ottava
$7,631 交易量
Yes
Vaccine
$7,002 交易量
No
Vaccine
$7,002 交易量
No
Procedure
$665 交易量
Yes
Procedure
$665 交易量
Yes
Europe
$568 交易量
Yes
Europe
$568 交易量
Yes
Carvykti
$355 交易量
Yes
Carvykti
$355 交易量
Yes
Rybrevant
$2,497 交易量
Yes
Rybrevant
$2,497 交易量
Yes
Trufill
$2,551 交易量
No
Trufill
$2,551 交易量
No
Administration
$16,687 交易量
Yes
Administration
$16,687 交易量
Yes
China
$254 交易量
Yes
China
$254 交易量
Yes
規則
This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
建立於: Jan 12, 2026, 12:39 PM ET
交易量
$43,288結束日期
Jan 21, 2026建立於
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...已提議結果: Yes
無爭議
最終結果: Yes
What will Johnson & Johnson say during their next earnings call?
$43,288 交易量
Nipocalimab / Lupus
$339 交易量
Yes
Halda Therapeutics / Haida Therapeutics
$4,472 交易量
是
Darzalex Faspro
$266 交易量
No
Ottava
$7,631 交易量
Yes
Vaccine
$7,002 交易量
No
Procedure
$665 交易量
Yes
Europe
$568 交易量
Yes
Carvykti
$355 交易量
Yes
Rybrevant
$2,497 交易量
Yes
Trufill
$2,551 交易量
No
Administration
$16,687 交易量
Yes
China
$254 交易量
Yes
關於
交易量
$43,288結束日期
Jan 21, 2026建立於
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...注意外部連結。
注意外部連結。

注意外部連結。
注意外部連結。